2025–2026 Flu Season: Self-Administered Vaccines
The 2025–2026 flu season marks the first widespread availability of AstraZeneca’s FluMist for self-administration at home. Following FDA approval in late 2024, the nasal spray vaccine can now be ordered online and administered by the patient or a caregiver without a clinic visit. This "Direct-to-Consumer" vaccination model is designed to increase public access and improve...
0 Комментарии 0 Поделились 12 Просмотры 0 предпросмотр